ABBV
AbbVie Inc
AbbVie is a large-cap pharmaceutical company with major exposure to immunology, aesthetics, and neuroscience. Investors focus on how the company balances commercial durability with ongoing pipeline replacement.
Company Sector
CNS
60 companies tagged with CNS.
CNS refers to central nervous system diseases such as depression, schizophrenia, epilepsy, Alzheimer’s disease, Parkinson’s disease, and other neurological or psychiatric conditions. Companies on this page are grouped by their exposure to brain and nervous system therapeutics.
ACIU
AC Immune
AC Immune is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ACAD
ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
AKUS
Akouos
Akouos is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ALNY
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is an RNA medicines company focused on gene-silencing therapeutics across rare and specialty diseases. Investors watch platform execution, label expansion, and how new programs broaden the franchise.
ATHE
Alterity Therapeutics
Alterity Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
AMPH
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
AMLX
Amylyx
Amylyx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
APTX
Aptinyx
Aptinyx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ARGX
Argenx
Argenx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ASRT
Assertio
Assertio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
ATHA
Athira Pharma
Athira Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
AXGN
AxoGen
AxoGen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
AXNX
Axonics
Axonics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
AXSM
Axsome
Axsome is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
BIIB
Biogen
Biogen is a neuroscience-focused biopharmaceutical company with a commercial base and a pipeline tied to central nervous system and specialty-disease opportunities. Investors watch the stock for pipeline refresh and the durability of its commercial mix.
BNOX
Bionomics
Bionomics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
BIVI
BioVie Inc.
BioVie is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
BTAI
BioXcel
BioXcel is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
SAVA
Cassava Sciences
Cassava Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
CPRX
Catalyst Pharmaceutical
Catalyst Pharmaceutical is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
CGTX
Cognition Therapeutics
Cognition Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
DNLI
Denali Therapeutics
Denali Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
ECOR
electroCore
electroCore is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
LLY
Eli Lilly
Eli Lilly is a large-cap pharmaceutical company with major exposure to cardiometabolic disease, neuroscience, and oncology. Investors track the stock for commercial scale, label expansion, and a pipeline that still carries meaningful growth optionality.
ELYM
Eliem Therapeutics
Eliem Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
FRX
Forest Laboratories
Forest Laboratories is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
HSDT
Helius Medical Technologies
Helius Medical Technologies is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
ITCI
Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
LEGN
Legend Biotech Corporation
Legend Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
LBPH
Longboard Pharmaceuticals
Longboard Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
MNMD
MindMed
MindMed is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
NERV
Minerva Neuroscience
Minerva Neuroscience is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
NGEN
NervGen Pharma
NervGen Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
NMRA
Neumora Therapeutics
Neumora Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
NBIX
Neurocrine Biosciences
Neurocrine Biosciences is a neuroscience-focused biopharmaceutical company with a commercial base and a pipeline tied to movement disorders and other specialty indications. Investors watch how the company extends its franchise beyond the lead commercial asset.
NGNE
Neurogene
Neurogene is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
NURO
Neurometrix
Neurometrix is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
STIM
Neuronetics
Neuronetics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
NRSN
NeuroSense Therapeutics
NeuroSense Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
NKGN
NKGen Biotech, Inc.
NKGen Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
NLSP
NLS Pharmaceutics Ltd.
NLS Pharmaceutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
NVS
Novartis AG
Novartis AG is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
NRXP
NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
ORPH
Orphazyme
Orphazyme is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
KTTA
Pasithea Therapeutics
Pasithea Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
PXMD
PaxMedica
PaxMedica is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
PMN
ProMIS Neurosciences
ProMIS Neurosciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
SRPT
Sarepta Therapeutics
Sarepta Therapeutics is a genetic medicines company focused on neuromuscular disease, with investors watching how its RNA and gene-therapy programs translate into durable clinical and commercial value.
SIOX
Sio Gene Therapies
Sio Gene Therapies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
SUPN
Supernus
Supernus is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
SNPX
Synaptogenix
Synaptogenix is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
TAK
Takeda
Takeda is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
TEVA
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
TNXP
Tonix Pharmaceuticals
Tonix Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
VTRS
Viatris Inc.
Viatris is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
VIGL
Vigil Neuroscience
Vigil Neuroscience is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
XENE
Xenon
Xenon is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
YMTX
Yumanity Therapeutics
Yumanity Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
ZLAB
Zai Lab Limited
Zai Lab Limited is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.